New insertable cardiac monitors show high diagnostic yield and good safety profile in real-world clinical practice: results from the international prospective observational SMART Registry
Europace · 2023
DOI: 10.1093/europace/euad068 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Europace, 2023. Verfasst von Fabio Quartieri und 14 weiteren Autor:innen. Beteiligte Einrichtung: Arcispedale Santa Maria Nuova, Viale Risorgimento, 80, 42123 Reggio Emilia, Italy. Hauptthemen laut MEDLINE: Atrial Fibrillation, Ischemic Stroke. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Abbott.
Abstract (Originalsprache)
Aims
Insertable cardiac monitors (ICMs) are indicated for long-term monitoring of unexplained syncope or palpitations, and for detection of bradycardia, ventricular tachycardia, and/or atrial fibrillation (AF). The aim of our study was to evaluate the safety and clinical value associated with a new generation ICM (Confirm Rx™, Abbott, Illinois, USA), featuring a new remote monitoring system based on smartphone patient applications. Methods and results The SMART Registry is an international prospective observational study. The main endpoints were ICM safety (incidence of serious adverse device and procedure-related events (SADEs) at 1 month), ICM clinical value (incidence of device-detected true arrhythmias and of clinical diagnoses and interventions), and patient-reported experience measurements (PREMs). A total of 1400 subjects were enrolled. ICM indications included syncope (49.1%), AF (18.8%), unexplained palpitations (13.6%), risk of ventricular arrhythmia (6.6%), and cryptogenic stroke (6.0%). Freedom from SADEs at 1 month was 99.4% (95% Confidence Interval: 98.8–99.7%). In the 6-month monitoring period, the ICM detected true cardiac arrhythmias in 45.7% of patients and led to clinical interventions in a relevant proportion of patients; in particular, a pacemaker implant was performed after bradycardia detection in 8.9% of subjects who received an ICM for syncope and oral anticoagulation therapy was indicated after AF detection in 15.7% of subjects with cryptogenic stroke. PREMs showed that 78.2% of subjects were satisfied with the remote monitoring patient app.
Conclusion
The evaluated ICM is associated with an excellent safety profile and high diagnostic yield. Patients reported positive experiences associated with the use of their smartphone for the device remote monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Arcispedale Santa Maria Nuova, Viale Risorgimento, 80, 42123 Reggio Emilia, Italy.
- Erlanger Medical Center, 975 E 3rd St, Chattanooga, TN 37403, USA.
- Policlinico Casilino, Via Casilina, 1049, 00169 Roma, Italy.
- Netcare Unitas Hospital, 866 Clifton Ave, Die Hoewes, Centurion, 0163, South Africa.
- Casa di Cura Pederzoli, Via Monte Baldo 24, 37019 Peschiera del Garda, VeronaItaly.
- Bay Area Cardiology Associates, 635 Eichenfeld Dr, Brandon, FL 33511, USA.
ORCID-Profile: Fabio Quartieri, Manyam Harish, Leonardo Calò, Iftikhar Ebrahim, Filippo Cauti, Seung-Jung Park, Pietro Francia, Marco Giovagnoni, Pedro Adragao, Andrea Grammatico
Förderung
- Abbott
Zitieren
APA
Quartieri, F., Harish, M., Calò, L., Ebrahim, I., Fusco, A., Mester, S., Cauti, F., Park, S. J., Francia, P., Giovagnoni, M., Adragao, P., Vezi, B., Lin, W., Hutson, C. S., & Grammatico, A. (2023). New insertable cardiac monitors show high diagnostic yield and good safety profile in real-world clinical practice: results from the international prospective observational SMART Registry. Europace. https://doi.org/10.1093/europace/euad068
Vancouver
Quartieri F, Harish M, Calò L, Ebrahim I, Fusco A, Mester S, et al. New insertable cardiac monitors show high diagnostic yield and good safety profile in real-world clinical practice: results from the international prospective observational SMART Registry. Europace. 2023. doi:10.1093/europace/euad068
BibTeX
@article{Quartieri2023,
author = {Quartieri, Fabio and Harish, Manyam and Calò, Leonardo and Ebrahim, Iftikhar and Fusco, Antonio and Mester, Stephen and Cauti, Filippo and Park, Seung-Jung and Francia, Pietro and Giovagnoni, Marco and Adragao, Pedro and Vezi, Brian and Lin, Wenjiao and Hutson, Chananit Sintuu and Grammatico, Andrea},
title = {New insertable cardiac monitors show high diagnostic yield and good safety profile in real-world clinical practice: results from the international prospective observational SMART Registry},
journal = {Europace},
year = {2023},
doi = {10.1093/europace/euad068}
}
EUVIMED